Published recently in JAMA https://jamanetwork.com/journals/jamaneurology/fullarticle/2687472 Yale’s Ziba Kashef reported “researchers have tested a new method for directly measuring synaptic loss in […]
BioHaven Pharmaceuticals announced the outcome from a focused analysis of the topline co-primary and key secondary data from its Phase […]
Eumentis Therapeutics announced the closing of its $3.9 million Series A financing. Proceeds from the financing will be used to […]
EIP Pharma announced positive results from the Phase 2 AscenD-LB study in patients with mild-to-moderate dementia with Lewy bodies (DLB). […]
Neurotherapia announced the closing of its Series A financing for $8.8M. The Series A round was led by Brain Trust Accelerator […]
Marinus Pharmaceuticals announced positive results from the phase 3 MARIGOLD study, which evaluated oral ganaxolone in children and young adults […]
Biohaven Pharmaceuticals announced positive topline results from its proof of concept study of troriluzole in the treatment of obsessive-compulsive disorder (OCD). […]
University of Illinois College of Medicine Rockford researchers received a five-year grant totaling over $1.8 million from the National Institutes […]
Emory University faculty and staff conduct research across every discipline. The Emory News Center recently published a summary of highlights […]
Researchers from the Medical Research Council (MRC) London Institute of Medical Sciences report that based on a recent study powered by […]
